Lee R. Mitau
and as a member of the Board, effective January 23, 2025
Highest-materiality recent filing
H.B. Fuller refinances $1.12B credit facility, extends maturity to 2031, cuts margin 25bps
Refinanced $420M term A loans and $700M revolving loans; revolving commitments increased by $100M to $800M.
H.B. Fuller to acquire Advanced Medical Solutions for £2.85/share, ~£715M enterprise value
Offer price of 285p per AMS share in cash; total enterprise value £715M.
H.B. Fuller Q2 adjusted EPS $1.41 (+19% YoY); raises FY adjusted EBITDA and EPS guidance
Revenue $950M (+5.8% YoY); organic +2.6%; adjusted EBITDA $181M (+9%).
H.B. Fuller Q1 adj EPS $0.57 (+6% YoY); raises FY adj EBITDA and EPS guidance
Adj EPS $0.57, up 6% YoY; reported EPS $0.38. Net income $21M.
H.B. Fuller Q4 adjusted EPS $1.28 (+39% YoY); FY2026 guidance $630-660M EBITDA
Q4 net revenue $895M (-3.1% YoY); adjusted gross margin 32.5% (+290bps YoY).
Net revenue $892M down 2.8% YoY; excluding flooring divestiture up 1.6%.
H.B. Fuller Q2 adj. EPS $1.18 beats, raises FY guidance; EBITDA margin up 130bps
Net revenue $898M (-2.1% YoY); adjusted EPS $1.18 (+5% YoY).
H.B. Fuller Q1 revenue $789M, organic up 1.9%; adj EPS $0.54; FY guidance reaffirmed
Reported net income $13M ($0.24 diluted EPS); adjusted net income $30M ($0.54 adjusted EPS).
H.B. Fuller Reports Q4 and Fiscal Year 2024 Results: Net Income $130M, Adjusted EBITDA $594M
Fiscal year 2024 net revenue $3.57B, up 1.6% YoY; organic revenue down 1.0% due to 2.7% unfavorable pricing offset by 1.7% higher volume.
H.B. Fuller preliminary FY2024 adj. EBITDA ~$594M, below prior $610-620M guidance
Net revenue expected ~$3.57B, adjusted diluted EPS ~$3.84, adjusted EBITDA ~$594M.
H.B. Fuller Q3 adj EPS $1.13 (+7% YoY); rev $918M (+1.9%); FY adj EBITDA guide $610-620M
Reported EPS $0.98; adjusted EPS $1.13 (up 7% YoY); net income $55M.
Adjusted diluted EPS of $1.12, up 20% YoY; net income of $51M; reported EPS $0.91.
H.B. Fuller Q1 adjusted EPS up 22% to $0.67; revenue slightly up to $810M
Adjusted EPS $0.67 (diluted), up 22% YoY; adjusted EBITDA $123M, up 12% YoY.
H.B. Fuller Q4 adjusted EPS $1.32 beats prior year; guides FY2024 up 7-15%
Q4 revenue $903M (-5.8% YoY); organic revenue -3.5%; adjusted gross margin 31.3% (+510bps).
H.B. Fuller Q3 net income $38M; revenue $901M; adj. EBITDA +13% to $156M
Reported EPS $0.67; adjusted EPS $1.06 flat YoY; revenue down 4.3% (organic -7.4%).
H.B. Fuller Q2 2023: Adj EBITDA $143M inline; revenue down 9.6% YoY to $898M
Adjusted gross margin expanded 330 bps YoY to 29.0%, driving margin improvement.
Net revenue $809M, down 5.5% YoY; organic revenue down 2.5% on 10.8% volume decline offset by 8.3% pricing.
H.B. Fuller FY2022 revenue $3.75B (+14%), adj EPS $4.00 (+15%); guides FY23 adj EPS $4.15-$4.55
FY2022 net revenue $3.75B, up 14% YoY; organic revenue up 17% with pricing up 16% and volume up 1%.
Celeste Mastin appointed H.B. Fuller President & CEO effective Dec. 4, succeeding Jim Owens
Jim Owens retires as President and CEO effective Dec 3, 2022; will assist transition through Dec 31.
H.B. Fuller Q3 adjusted EPS $1.06 (+34% YoY); raises FY adj. EBITDA view to $540-550M
Net revenue $941.2M, +13.8% YoY; organic revenue +18.4% driven by pricing actions.
H.B. Fuller Q2 revenue $993M (+20% YoY); adj. EPS $1.11 (+18%); guides FY adj. EBITDA $530-550M
Record quarterly revenue of $993M; organic revenue up 22% YoY with 3.4% volume growth and 18.5% pricing.
H.B. Fuller raises quarterly dividend 13% to $0.19; authorizes $300M share repurchase
Quarterly dividend increased 13% from $0.1675 to $0.19 per share, payable May 5, 2022 to shareholders of record April 21, 2022.
H.B. Fuller Q1 adj EPS $0.80 (+21% YoY); raises FY22 adj EPS guidance to $4.10-4.35
Net revenue $857M (+18% YoY); organic revenue up 21% (6.1% volume, 14.7% pricing).
H.B. Fuller appoints Celeste Mastin as EVP & COO effective March 7, 2022
Ted Clark moves from COO to strategic advisory role effective March 7.
H.B. Fuller acquires Apollo Chemicals, Fourny nv for $211M total; expects $8M annual synergies
Total purchase price $211M; multiple 12.3x EBITDA before synergies, 8.4x after expected $8M annual run-rate synergies.
H.B. Fuller Q4 rev $897M (+15% YoY), adj EPS $1.09; FY22 adj EPS guidance $4.00-$4.25
Q4 net income $65M, diluted EPS $1.18; adjusted EPS $1.09 vs $1.06 a year ago.
H.B. Fuller Q3 revenue $827M (+20% YoY); raises FY revenue guidance to 17-18% growth
Organic revenue up 16% (10% volume, 6% pricing); adjusted EPS $0.79 vs $0.76 prior year.
and as a member of the Board, effective January 23, 2025
Lee R. Mitau, Chair of the Board of Directors (the “Board”) of H.B. Fuller Company (the “Company”), notified the Company of his retirement as Chair, effective January 21, 2025
On October 1, 2024, Traci L. Jensen, Executive Vice President and Chief Administrative Officer of H.B. Fuller Company (the “Company”), notified the Company of her retirement, effective November 30, 2024.
On November 29, 2022, the Board of Directors of H.B. Fuller Company (the “Company”) elected Charles (“Chuck”) T. Lauber, age 60, as a Class II director of the Company, effective January 23, 2023, for an initial term expiring at the Company’s 2025 annual meeting of shareholders.
James J. Owens will retire from both the Board of Directors of the Company and the position of President and Chief Executive Officer of the Company, effective December 3, 2022.
Celeste B. Mastin has been appointed President and Chief Executive Officer of the Company, effective December 4, 2022.
Ms. Mastin has also been elected to the Board of Directors of the Company, effective December 4, 2022.
accepted the resignation of Dante C. Parrini as a director of the Company.
Effective March 7, 2022, Theodore M. Clark, Executive Vice President and Chief Operating Officer of H.B. Fuller Company (the "Company"), will transition from the Chief Operating Officer role and move into a strategic advisory role with the Company.
On February 23, 2022, the Company announced the election of Celeste B. Mastin as the Executive Vice President and Chief Operating Officer of the Company, effective March 7, 2022.
John C. van Roden, Jr. notified the Board of Directors of H.B. Fuller Company (the “Company”) of his retirement as a director of the Company effective at the end of his current term, April 7, 2022.
elected Dr. Srilata ("Sri") Zaheer as a Class I director of the Company, effective April 6, 2022
Max materiality 0.85 · Median 0.68 · Most common event earnings